Why Biogen Stock Got Mashed on Monday

Healthcare company Biogen (NASDAQ: BIIB) wasn’t looking very healthy on the stock market on Monday. Investors traded out of its shares after learning that the company plans to book a hefty charge in its first quarter, which will directly affect its bottom line. By the end of the day, Biogen’s stock had lost nearly 3% of its value.

Before market open, Biogen divulged in a regulatory filing that it expects to record $34 million in pre-tax expenses in its first quarter of this year. These consist of in-process research and development costs, as well as upfront and milestone payments.

Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an “Indispensable Monopoly” providing the critical technology Nvidia and Intel both need. Continue »

Image source: Getty Images.

That charge will likely impact the company’s net income by roughly $0.19 per share under both generally accepted accounting principles (GAAP) and non-GAAP standards.

Also on Monday, the biotech set the date for its earnings release detailing that quarter’s performance. This is slated to occur before market open on Wednesday, April 29.

Investors tracking Biogen stock were expecting the company to post only a slight year-over-year gain in headline net income, to $2.95 per share. However, most, if not all, of those estimates came before the company announced the $34 million charge.

The past few weeks have been eventful for Biogen; at the end of last month, it announced it was spending around $5.6 billion to acquire Apellis Pharmaceuticals.

Investors weren’t happy to hear that news either, but I think they should give Biogen more of a chance. It’s doing a good job pivoting from its traditional but unsustainable strength in multiple sclerosis therapies into higher-potential segments. Transitions in the healthcare industry tend to be rocky at times, so the latest developments with the company don’t spook me. Biogen remains a quality stock.

Before you buy stock in Biogen, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Biogen wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $532,066!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,087,496!*

Source link

Visited 1 times, 1 visit(s) today

Related Article

Weekly share repurchase program transaction details

Amsterdam, November 18, 2026 SBM Offshore reports the transaction details related to its EUR227 million (US$270 million1) share repurchase program for the period November 12, 2026 through November 18, 2026. The repurchases were made under the EUR227 million share repurchase program announced on February 26, 2026 and effective from February 27, 2026. The objective of

Five Below vs. Uber Technologies: Which Consumer Stock Is a Better Buy for 2027?

Five Below’s aggressive store push and Uber’s global platform scale pull in very different directions, and the valuation gap may tip the balance for 2027. By Brendan Coffey – Updated Nov 18, 2026 at 10:50AM EST Key Points Five Below is leveraging an aggressive store expansion strategy to capture more of the teen and tween

Why the Anthropic IPO could be a trap for investors

Anthropic’s IPO is Wall Street’s Black Friday doorbuster. But IPO history says whatever you grab on day one usually goes on sale later. Anthropic (ANT) is expected to price its shares Wednesday evening and start trading Thursday on the Nasdaq. Orders reportedly came in at nearly seven times the shares on offer, and the top

Stock Market Correction: 2 AI Stocks With 130% and 160% Upside, According to Wall Street.

The Nasdaq Composite (^IXIC -0.74%) entered correction territory earlier this month amid concerns about the sustainability of the artificial intelligence boom. But history says the sell-off is a buying opportunity. In the last decade, the index returned an average of 21% during the year following its first close in correction territory. Wall Street analysts see

AST SpaceMobile Is 78% Below Its High and Pushed Its Launch Target to 2027. Here’s the Exact Price Where I’d Finally Buy.

AST SpaceMobile‘s (ASTS -3.46%) stock closed at a record high of $133.09 per share on May 28, 2026. But today, the satellite maker’s stock trades at about $29 per share. Why did AST’s stock plummet 78%? AST produces low-Earth orbit (LEO) satellites for cellular connectivity. It helps wireless carriers, including AT&T (T -0.31%) and Verizon

The changing stock market reaction to inflation surprises

I keep coming back to this post on why I think working in finance is so fascinating and never boring. Things change all the time. And even if the same thing happens again and again, stocks, bonds and other assets react differently to the same event all the time. That post looked at stock market

What Is Behind AMD Stock’s Nearly 6% Slide?

Image from Pixabay Today’s big story: Could Nvidia Stock Fall 50%? Follow The Cash Shares of Advanced Micro Devices (AMD) fell 5.6% on Monday, November 16, 2026, while the S&P 500 lost 1.9%. The decline came the day the company said it had completed its purchase of World Labs. All five chipmakers on its peer

Unitedhealth Group Inc Stock (UNH) Opened Down by 4.78% on Nov 17: What Investors Need To Know

UnitedHealth Group experienced notable downward pressure during the session, driven primarily by persistent concerns over elevated medical cost trends and ongoing regulatory overhang across the managed care sector. A significant headwind for the company continues to center on medical utilization dynamics. Institutional investors remain exceptionally sensitive to indications that medical loss ratios are trending above

Down 56%, but this iconic FTSE 100 stock’s mounting a comeback

Image source: Getty Images There are few more recognisable brands in the FTSE 100 than Burberry (LSE:BRBY). Founded in 1856, the luxury fashion house is currently celebrating its 170th year. Investing in Burberry however, has been more of a liability than a luxury experience in recent years. Since hitting a peak of £26 in April

Nvidia Signals AI Financing Flywheel Will Continue, But ‘Disciplined’: Analyst Calls Neoclouds Its ‘Biggest Sustained Bet’ As NBIS, IREN, MRVL Rally

Nvidia reported Q3 results above expectations and raised its fiscal 2028 sales forecast. NBIS and IREN rose over 10% in overnight trading, while CRWV gained 9%. “The Neoclouds aren’t a nice to have for $NVDA. It’s the biggest sustained bet,” said analyst Daniel Newman. Nvidia Corp. (NVDA) on Tuesday said it will continue supporting the

BofA Tweaks Rolls-Royce Estimates Amid New Interim Share Buyback

Market Closed – 11:35:22 2026-11-17 am EST 5-day change 1st Jan Change 1,326.60 GBX -0.81% -0.32% +15.36% Published on 11/17/2026 at 11:06 am EST MT Newswires This article is reserved for our members. Log in to continue Log inCreate an account DurationAuto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax. PeriodDayWeek Rolls-Royce Holdings plc specializes

Daily Market Price Updates and Commentary 17th November 2026

  ICE Futures U.S. Sugar No.11 Contract Settlement (cUS$/lb) Open High Low Last Volume O/I Life High Life Low Mar27 18.17 0.07 ▲ 18.14 18.33 17.97 18.17 55,783 540,886 21.29 14.42 May27 17.60 0.01 ▲ 17.60 17.78 17.44 17.60 24,605 224,913 20.40 14.29 Jul27 17.24 -0.02 ▼ 17.26 17.40 17.11 17.23 15,295 146,817 19.81 14.27

Consumer staples stocks benefiting from a powerful rotation as tech gets slammed

Investors continue to find comfort in boring consumer staples stocks as growth expectations for the tech giants driving the AI boom come under closer scrutiny. The S&P 500 (^GSPC) tech sector’s (XLK) forward price-to-earnings (P/E) ratio is currently 17.2 times, its lowest level since 2020, according to data crunched by Duality Research. The S&P 500’s

A Strange Year in the Stock Market

For years now it felt like the only game in town was U.S. large cap growth stocks. That’s changed somewhat in the past few years. Growth stocks have still done fine, of course, what with the AI boom and all. But other areas of the market have come to life. Emerging markets have outperformed. International

0
Would love your thoughts, please comment.x
()
x